OncoSec Medical Incorporated Gains 42.23%
Mon, Nov 21, 2022 at 07:22 PM
OncoSec Medical Incorporated (ONCS:NASDAQ) soared at $4.85, representing a gain of 42.2%. The stock appeared on our News Catalysts scanner on Wed, Nov 16, 2022 at 09:58 AM in the 'BIOTECH' category. From Mon, Nov 07, 2022, the stock recorded 30.00% Up Days and 27.27% Green Days
About OncoSec Medical Incorporated (ONCS:NASDAQ)
OncoSec Medical Inc is a biotechnology company engaged in designing, developing and commercializing gene therapies, therapeutics and proprietary medical approaches to stimulate and guide an anti-tumor immune response for the treatment of cancer.
Top 10 Gainers:
- Imago BioSciences Inc. (IMGO:NASDAQ), 104.54%
- OncoSec Medical Incorporated (ONCS:NASDAQ), 42.23%
- Cardio Diagnostics Holdings Inc Com (CDIO:NASDAQ), 40.34%
- NWTN Inc. (NWTN:NASDAQ), 38.78%
- SeaStar Medical Inc Com (ICU:NASDAQ), 33.59%
- Sotera Health Company (SHC:NASDAQ), 32.89%
- GrafTech International Ltd. (EAF:NYSE), 31.28%
- Charah Solutions, Inc. (CHRA:NYSE), 31.14%
- uCloudlink Group Inc. (UCL:NASDAQ), 30.94%
- XL Group Ltd (XL:NYSE), 30.91%